Jiyya tare da maganin rigakafi iya muhimmanci ƙara hadarin ashara

Matan da suka dauki wasu iri maganin rigakafi a farkon matakai na ciki yana iya zama a ƙãra hadarin ashara, da masu bincike bayar da shawarar.

New data na Canada masana kimiyya

Amma ba duk maganin rigakafi ne guda, da kuma wasu na iya zama mafi aminci a lokacin daukar ciki fiye da wasu. Masu bincike na Canada gano cewa, mata masu juna biyu da suka yi amfani da wasu iri maganin rigakafi, da kadan karuwa a hadarin ashara a farkon 20 makonni na ciki, idan aka kwatanta da nan gaba uwãyensu wanda bai yi su. A sakamakon wannan binciken da aka buga May 1 a cikin Kanad Medical Association Journal.

"A binciken ya nuna cewa da aka fi amfani da maganin rigakafi - penicillin, cephalosporin da erythromycin - da wani sakamako a kan hadarin ashara," - ya ce gubar binciken marubucin Anick Berard, farfesa kantin magani a Jami'ar Montreal a Canada.

Cututtuka da cewa faruwa a mata a lokacin daukar ciki, ya kamata a bi, don haka shi ne gratifying sani cewa maganin rigakafi ne mafi yadu amfani, ba su da hanyar ashara a farkon daukar ciki.

tsaro da matsaloli

Duk da m amfani da maganin rigakafi a lokacin daukar ciki zuwa yi wa wani iri-iri na cututtuka, tsaro, da tasiri na wadannan kwayoyi a kan tayin da ya rage wani matsala, nazarin mawallafa ce. Wannan shi ne saboda baya karatu da dangantakar dake tsakanin yin amfani da maganin rigakafi a lokacin daukar ciki da kuma hadarin ashara kasance quite sabanin. Wasu masu bincike sun gano wata mahada tsakanin da amfani da wasu azuzuwan na maganin rigakafi a lokacin daukar ciki da kuma ashara, yayin da wasu ba a tabbatar.

A abũbuwan amfãni daga yin amfani da wani database

A cikin sabon binciken, masana kimiyya data a kan hanya na ciki a mata daga Quebec tsakanin 1998 da 2009 da aka yi karatu. Wannan database ƙunshi bayani a kan mata masu ciki a cikin lardin, wanda aka rufe da Quebec gwamnatin ta shirya a kan miyagun ƙwayoyi inshora. A database ya hada data game da mafi yawan mata masu ciki a lardin.

Saboda haka, masu bincike sun gaskata cewa su aka ta amfani da madaidaicin bayani game da takardar sayen magani ga maganin rigakafi, takardar sayen magani expectant iyaye mata, kyale su ba su dogara a kan ikon da mata mu tuna da abin da kwayoyi da suka kasance sunã, tun da shi ne a kasa m nuna alama.

Wanne maganin rigakafi ne mai hadarin gaske ga mata masu ciki

Da masu bincike idan aka kwatanta da lokuta na fiye da 8.700 mata da suka yi mai ashara a lokacin farko 20 makonni, daga 87 000 matan da suka yi ciki rikitarwa. Age na mata a cikin nazarin jeri daga 15 zuwa shekaru 45. Sai ya juya daga cewa game da 12 da 500 daga cikinsu sun riƙi maganin rigakafi a lokacin daukar ciki.

A binciken ya nuna cewa biyar azuzuwan na maganin rigakafi - macrolides, quinolones, tetracyclines, sulfonamides da metronidazole - zai iya kara hadarin ashara, idan wata mace ne a farkon matakai na ciki. Masana kimiyya sun lura da cewa daya macrolide maganin rigakafi - erythromycin - aka ba a hade tare da wannan hadarin.

Wadannan bayanai sun yi daidai da sakamakon samu a cikin shakka daga wasu gabata karatu, amma jam'iyya tsakanin fluoroquinolones da tetracyclines, da kuma hadarin ashara ba a baya gano. Duk da haka, a halin yanzu obstetricians ba da shawarar yin amfani da fluoroquinolones da tetracyclines a farkon matakai na ciki, da kuma wadannan sakamakon bayar da shawarar cewa wannan shawara sa hankali.

low hadarin

"Ko da yake nazari samu wani ƙãra hadarin ashara a matan da suka dauki wasu iri maganin rigakafi, da kanta ba high," - ya ce Farfesa Berard. A amfani da wasu magunguna, kamar nonsteroidal anti-kumburi kwayoyi da kuma antidepressants ma ya hade da wani irin karin hadarin ashara.

Rage hašarin ashara

Wani mai kyau labarai ne cewa kowa da kwayoyin - nitrofurantoin, wanda sau da yawa wajabta idan mace na da urinary fili cututtuka, aka zahiri hade tare da rage hadarin ashara idan aka kwatanta da iko kungiyar. Wannan shi ne na farko nazari cewa, ya nuna wannan dangantaka, domin a nan gaba, masana kimiyya za su bukatar tabbatar da wannan sabon binciken.